(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Holiday Inn London Kensington Forum

14 jun 2016 12:30 p.m. - 15 jun 2016 4:30 p.m.

97 Cromwell Road, London, SW7 4DN, United Kingdom

DILI: Clinical Trials and Post-Marketing

This course is led by a Hepatologist with extensive experience in clinical assessment of DILI and who published ‘RUCAM’ the widely used causality assessment method of DILI.

Registrarse

Volver a Agenda

SESSION 2: EPIDEMIOLOGY, DEFINITIONS AND CLASSIFICATION OF DILI

Session Chair(s)

Gaby L. Danan, MD, PHD

Gaby L. Danan, MD, PHD

Pharmacovigilance Expert

GLD, France

  • Current biomarkers of DILI: Description and limitations
  • DILI risk factors
  • Case studies

Speaker(s)

Gaby L. Danan, MD, PHD

EPIDEMIOLOGY, DEFINITIONS AND CLASSIFICATION OF DILI

Gaby L. Danan, MD, PHD

GLD, France

Pharmacovigilance Expert

¿Tiene una cuenta?

Registrarse

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.